The CD200R1 microglial inhibitory receptor as a therapeutic target in the MPTP model of Parkinson’s disease

Overview of attention for article published in Journal of Neuroinflammation, April 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 1 news outlet

twitter: 8 X users

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 24 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 1 news story.

The CD200R1 microglial inhibitory receptor as a therapeutic target in the MPTP model of Parkinson's disease.

Alzforum, 16 Apr 2021

Rabaneda-Lombarte N, Serratosa J, Bové J, Vila M, Saura J, Solà C. The CD200R1 microglial inhibitory receptor as a therapeutic…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.